Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

$22.49

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Analysis of Investments

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Adjustment to Net Income (Loss): Mark to Market Available-for-sale Securities

Abiomed Inc., adjustment to net income

US$ in thousands

Microsoft Excel
12 months ended: Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net income (as reported)
Add: Net unrealized gains (losses) on marketable securities, net of tax
Net income (adjusted)

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


The financial data reveals significant fluctuations in both reported and adjusted net income over the six-year period from March 31, 2017, to March 31, 2022.

Reported Net Income
Reported net income exhibited a strong upward trajectory from 2017 through 2019, increasing from 52,116 thousand US dollars to a peak of 259,016 thousand US dollars in 2019. This represents nearly a fivefold increase within this three-year span. In 2020, there was a notable decline, with net income decreasing to 203,009 thousand US dollars, a reduction of approximately 22% from the previous year. The value rose slightly in 2021 to 225,525 thousand US dollars before a further decline to 136,505 thousand US dollars in 2022, marking nearly a 40% drop from the prior year.
Adjusted Net Income
The pattern observed in adjusted net income closely mirrors that of the reported figures, indicating that adjustments had a minimal effect on the net income trends. Beginning at 51,905 thousand US dollars in 2017, the adjusted net income rose steadily to reach its highest point of 259,962 thousand US dollars in 2019, representing a more than fivefold increase. Post-2019, adjusted net income experienced a decline to 204,342 thousand US dollars in 2020, followed by a modest recovery to 225,222 thousand US dollars in 2021. Subsequently, there was a significant drop to 128,413 thousand US dollars in 2022, reflecting a downward trend similar to the reported net income.
Overall Observations
The financial data shows robust growth in net income during the initial years, culminating in 2019, with clear peak performance. However, beginning in 2020, both reported and adjusted net incomes declined substantially, suggesting the presence of headwinds or challenges impacting profitability. The relatively small differences between reported and adjusted net income imply that adjustments for non-recurring or non-operational items did not materially alter the income figures or their trend.

Adjusted Profitability Ratios: Mark to Market Available-for-sale Securities (Summary)

Abiomed Inc., adjusted profitability ratios

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
Net Profit Margin
Reported net profit margin
Adjusted net profit margin
Return on Equity (ROE)
Reported ROE
Adjusted ROE
Return on Assets (ROA)
Reported ROA
Adjusted ROA

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).


Net Profit Margin Trends
The reported net profit margin showed a significant increase from 11.7% in 2017 to a peak of 33.66% in 2019. This was followed by a decline to 24.14% in 2020, then a slight recovery to 26.61% in 2021, before falling sharply to 13.23% in 2022. The adjusted net profit margin follows a similar pattern, peaking at 33.79% in 2019, then decreasing to 12.45% in 2022. Overall, the margins exhibited volatility with a notable peak in 2019 followed by a downward trend through 2022.
Return on Equity (ROE) Trends
Reported ROE increased steadily from 11.53% in 2017 to a high of 27.65% in 2019. After the peak, there was a decline to 19.05% in 2020, and the downward trajectory continued to 9.08% in 2022. Adjusted ROE mirrors this trend, peaking at 27.75% in 2019 and then dropping to 8.54% in 2022. The data indicates diminishing returns on equity starting in 2020 and accelerating in the two subsequent years.
Return on Assets (ROA) Trends
Reported ROA rose from 9.47% in 2017 to 24.57% in 2019, marking a significant improvement in asset utilization profitability. It then declined to 16.69% in 2020 and further to 8.16% in 2022. Adjusted ROA shows a comparable trend, peaking at 24.66% in 2019, followed by declines to 7.67% by 2022. This pattern suggests decreasing efficiency in generating profits from assets after 2019.
General Observations
All key profitability metrics experienced substantial growth up to 2019, indicative of strong financial performance during that period. Post-2019, there is a consistent and notable decline across reported and adjusted net profit margins, ROE, and ROA through 2022. This downward trend may signal increasing challenges in maintaining profitability and operational efficiency in recent years.

Abiomed Inc., Profitability Ratios: Reported vs. Adjusted


Adjusted Net Profit Margin

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Revenue
Profitability Ratio
Net profit margin1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Revenue
Profitability Ratio
Adjusted net profit margin2

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 Net profit margin = 100 × Net income ÷ Revenue
= 100 × ÷ =

2 Adjusted net profit margin = 100 × Adjusted net income ÷ Revenue
= 100 × ÷ =


Net Income Trends
The reported net income shows a general upward trend from 2017 to 2019, increasing substantially from $52,116 thousand to $259,016 thousand. However, it declines in 2020 to $203,009 thousand, experiences a slight recovery in 2021 to $225,525 thousand, and then decreases again to $136,505 thousand in 2022.
The adjusted net income follows a similar pattern, rising from $51,905 thousand in 2017 to $259,962 thousand in 2019, then decreasing to $204,342 thousand in 2020, increasing slightly to $225,222 thousand in 2021, and falling to $128,413 thousand in 2022.
Net Profit Margin Trends
Reported net profit margin mirrors net income trends, showing an increase from 11.7% in 2017 to a peak of 33.66% in 2019, followed by a significant decline to 24.14% in 2020. It experiences a moderate increase to 26.61% in 2021 and subsequently decreases sharply to 13.23% in 2022.
Adjusted net profit margin also displays a similar pattern, rising from 11.66% in 2017 to a high of 33.79% in 2019. It then declines to 24.3% in 2020, increases slightly to 26.57% in 2021, and drops significantly to 12.45% in 2022.
General Observations
Both reported and adjusted net income as well as profit margins exhibit consistent trends over the examined period, with marked growth until 2019, followed by a fluctuation characterized by declines in 2020 and 2022 and a partial recovery in 2021.
The sharp decrease in net income and margins in 2022 compared to previous years suggests a challenging financial environment or operational difficulties impacting profitability during that period.
The close alignment between reported and adjusted figures indicates that adjustments have minimal impact on the overall profitability trends.

Adjusted Return on Equity (ROE)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Stockholders’ equity
Profitability Ratio
ROE1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Stockholders’ equity
Profitability Ratio
Adjusted ROE2

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × ÷ =

2 Adjusted ROE = 100 × Adjusted net income ÷ Stockholders’ equity
= 100 × ÷ =


The data reveals notable fluctuations and trends in the net income and return on equity (ROE) for the periods analyzed. Both reported and adjusted net income demonstrate a general upward trend until the fiscal year ending March 31, 2019, where they peak significantly before experiencing volatility in subsequent years.

Net Income Analysis
Reported net income increased from approximately 52.1 million USD in 2017 to a peak of around 259 million USD in 2019, reflecting substantial growth. Subsequently, it declined to about 203 million USD in 2020 but recovered somewhat in 2021 to over 225 million USD. However, there was a marked drop in 2022, where net income fell to approximately 136.5 million USD.
Adjusted net income follows a very similar pattern, with values slightly lower or higher than reported net income. It similarly reached a peak in 2019 around 260 million USD, dipped in 2020, partially rebounded in 2021, and then decreased notably in 2022 to close to 128.4 million USD.
Return on Equity (ROE) Analysis
Reported ROE reflects an increasing trend from 11.53% in 2017 to a high of 27.65% in 2019, indicating improved profitability relative to equity during this period. However, this ratio experienced a decline afterwards, falling to 19.05% in 2020 and then to 16.96% in 2021, before a sharper decrease to 9.08% in 2022.
Adjusted ROE mirrors the reported ROE closely, peaking at 27.75% in 2019 and subsequently decreasing to 19.18% in 2020 and 16.94% in 2021, followed by a more pronounced drop to 8.54% in 2022.

Overall, the data depicts a period of strong growth culminating in 2019, followed by a period of volatility and gradual decline in both net income and ROE metrics in the years after, particularly towards 2022. This trend suggests challenges impacting profitability and returns on equity in the most recent reporting period.


Adjusted Return on Assets (ROA)

Microsoft Excel
Mar 31, 2022 Mar 31, 2021 Mar 31, 2020 Mar 31, 2019 Mar 31, 2018 Mar 31, 2017
As Reported
Selected Financial Data (US$ in thousands)
Net income
Total assets
Profitability Ratio
ROA1
Adjusted: Mark to Market Available-for-sale Securities
Selected Financial Data (US$ in thousands)
Adjusted net income
Total assets
Profitability Ratio
Adjusted ROA2

Based on: 10-K (reporting date: 2022-03-31), 10-K (reporting date: 2021-03-31), 10-K (reporting date: 2020-03-31), 10-K (reporting date: 2019-03-31), 10-K (reporting date: 2018-03-31), 10-K (reporting date: 2017-03-31).

2022 Calculations

1 ROA = 100 × Net income ÷ Total assets
= 100 × ÷ =

2 Adjusted ROA = 100 × Adjusted net income ÷ Total assets
= 100 × ÷ =


Net Income Trends
The reported net income exhibited a substantial increase from 52,116 thousand USD in 2017 to a peak of 259,016 thousand USD in 2019, representing nearly a fivefold growth over two years. After 2019, net income declined, dropping to 203,009 thousand USD in 2020, recovering slightly in 2021 to 225,525 thousand USD, and then decreasing again in 2022 to 136,505 thousand USD. The adjusted net income followed a very similar pattern, starting at 51,905 thousand USD in 2017, peaking at 259,962 thousand USD in 2019, and subsequently declining to 128,413 thousand USD in 2022. This pattern indicates a strong growth period early on, followed by volatility and a downward trend in recent years.
Return on Assets (ROA) Analysis
The reported ROA improved notably from 9.47% in 2017 to a high of 24.57% in 2019, aligning with the peak net income years. This increase suggests enhanced profitability relative to asset base during that period. After 2019, the reported ROA decreased significantly to 8.16% by 2022, indicating reduced efficiency or profitability in asset utilization. The adjusted ROA mirrors this trend, rising from 9.43% in 2017 to 24.66% in 2019, then declining steadily to 7.67% in 2022. The adjusted figures confirm that the observed trends are consistent even after making investment adjustments.
Overall Insights
The financial performance experienced considerable growth up to the fiscal year ending in March 2019, followed by a period of decline in both net income and return on assets through 2022. The close alignment between reported and adjusted figures throughout suggests that non-operating or one-time adjustments had minimal impact on the overall trend in profitability. The sharp reduction in profitability metrics post-2019 warrants further investigation into operational challenges, market conditions, or strategic changes affecting financial outcomes.